Category Archives: Pr Newswire

Frost & Sullivan Institute Celebrates Visionary Companies Addressing the World’s Most Pressing Challenges

SILICON VALLEY, Calif., June 16, 2026 /PRNewswire/ — The Frost & Sullivan Institute is pleased to present the 2026 Visionary Growth Leadership Best Practices Recognition, celebrating leading enterprises that are redefining the role of business in addressing the world’s most urgent challenges. This recognition honors organizations that have embedded innovation, measurable impact, and long-term sustainability […]

Six Regional Organisations Sign MoU to Strengthen Asia’s Dengue Response as Cases Rise

Announced at the 9th Asia Dengue Summit in conjunction with ASEAN Dengue Day and the first WHO-recognised World Dengue Day, the MoU establishes a regional framework for knowledge-sharing, advocacy and coordinated dengue action. SINGAPORE, June 15, 2026 /PRNewswire/ — The Asia Dengue Voice and Action Group (ADVA) and partner organisations from across Asia have signed […]

APP Group Highlights the Role of Sustainable Products for Hospitality and F&B Ahead of World Cup 2026

ORANGE, Calif., June 15, 2026 /PRNewswire/ — APP Group highlights the growing role of sustainable paper-based products for hospitality and food and beverage businesses as they prepare for World Cup 2026. With 48 teams and 104 matches across Canada, Mexico, and the United States, the tournament is expected to bring a sharp rise in visitors, […]

ONLYOFFICE DocSpace 3.7 released: AI file generation, smarter forms, and updated editors

SINGAPORE, June 15, 2026 /PRNewswire/ — ONLYOFFICE releases DocSpace 3.7, the newest version of its room-based collaboration platform. A major update adds new AI capabilities, a redesigned form filling experience, updated editors, and stronger security controls. The release touches nearly every part of the platform and is already available for users. ONLYOFFICE DocSpace 3.7 released. […]

Bambusa Therapeutics Presents Positive Preliminary Multiple Ascending Dose Phase 1 Data for BBT002 at the European Academy of Allergy & Clinical Immunology (EAACI) Annual Congress 2026

– BBT002 is a next-generation, long-acting bispecific antibody targeting two clinically and commercially validated targets, IL-4Rα and IL-5 – – BBT002 demonstrated rapid, deep, and sustained biomarker effects through at least 8 weeks following multiple doses, consistent with the SAD data, with a ~29.4-day half-life supporting extended dosing intervals – – Topline data from ongoing […]

Monport Highlights Growing Demand for Personalized Father’s Day Gifts Powered by Advanced Laser Engraving Technology

New laser engraving solutions help makers and businesses create custom Father’s Day gifts with greater precision, speed and material versatility NEW YORK, June 15, 2026 /PRNewswire/ — As consumers increasingly seek meaningful and personalized Father’s Day gifts, laser engraving technology is emerging as a powerful tool for transforming ordinary products into memorable keepsakes. From custom […]

BHN encourages Aussies to send the spirit of soccer this FIFA World Cup 2026™ season

SYDNEY, June 15, 2026 /PRNewswire/ — As the world gears up for the kick-off of this year’s premier football tournament, global leader in branded payments, Blackhawk Network (BHN), is partnering with Visa, the official Worldwide Partner of the FIFA World Cup 2026™, to launch a limited-edition digital FIFA World Cup 2026™ Activ Visa™ Gift Card. Available […]

Concept Study Identifies Potential Refining Pathway at Shaakichiuwaanaan to Battery-Grade Lithium Carbonate

Study highlights potential to produce a value-added lithium chemical at site, offering further opportunities to reduce logistics intensity over time and aligning with Canada’s and Québec’s objectives for domestic processing of critical minerals  MONTREAL, June 15, 2026 /PRNewswire/ — June 15, 2026 – Sydney, Australia  Highlights Concept study completed evaluating future potential to process spodumene […]

Menarini Group Reports Data from the Phase 3 SENTRY Trial of Selinexor Plus Ruxolitinib in Myelofibrosis at The European Hematology Association (EHA) 2026 Congress

The combination of selinexor plus ruxolitinib met the first co-primary endpoint demonstrating a statistically significant improvement of spleen volume reduction (SVR35) of 49.8% for the combination arm vs 28% for the control arm at week 24. Post-hoc analysis from the phase 3 SENTRY trial suggests SVR35 may predict overall survival (OS); new data from the […]